{
    "nctId": "NCT03255577",
    "briefTitle": "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy For Locally Advanced Breast Cancer",
    "officialTitle": "Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients Presenting With Locally Advanced Breast Cancer: A Prospective Study",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Locally Advanced Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "The false negative rate of sentinel lymph node biopsy in patients with locally advanced breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients over 18 years of age with biopsy-proven breast cancer\n* Patients presenting with locally advanced disease in the breast (cT4) and/or in the nodes (cN2/N3) as assessed by clinical exam and imaging\n* Patients presenting to surgery clinic after receipt of NAC at outside hospital with documentation of cT4 or cN2/3 disease on initial outside physical exam and imaging studies\n* Patients receiving NAC and having a nodal complete clinical response as assessed by physical exam\n\nExclusion Criteria:\n\n* Patients with a prior history of ipsilateral breast cancer\n* Pregnant patients\n* Patients with persistent palpable axillary nodes after NAC, as assessed by physical exam\n* Patients not consenting to ALND",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}